Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Journal for Immunotherapy of Cancer
|
July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancer
Kyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer
Jiyeon Yun, Min Hee Hong, Seok-Young Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer
Mi Ran Yun, Dong Hwi Kim, Seok-Young Kim, et al.
Cancer Discovery
|
May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion-Driven NSCLC
Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, et al.
EMBO Molecular Medicine
|
October 22, 2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun, Hun Mi Choi, You Won Lee, et al.
Journal of Hepatology
|
August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma
Hyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.
Clinical & Translational Immunology
|
January 10, 2022
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models
Chun-Bong Synn, Sung Eun Kim, Hee Kyu Lee, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Journal for Immunotherapy of Cancer
|
July 31, 2020
Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in <i>ALK</i>-positive non-small-cell lung cancer
Kyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer
Jiyeon Yun, Min Hee Hong, Seok-Young Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer
Mi Ran Yun, Dong Hwi Kim, Seok-Young Kim, et al.
Cancer Discovery
|
May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion-Driven NSCLC
Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, et al.
EMBO Molecular Medicine
|
October 22, 2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun, Hun Mi Choi, You Won Lee, et al.
Journal of Hepatology
|
August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma
Hyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.
Clinical & Translational Immunology
|
January 10, 2022
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models
Chun-Bong Synn, Sung Eun Kim, Hee Kyu Lee, et al.
Page
of 4